Brown Gibbons Lang & Company Research
Advisory Approach
Brown Gibbons Lang & Company (BGL) is a sector-focused, partnership-owned investment bank built on a thesis that middle market companies deserve senior-level attention from experienced bankers with deep industry knowledge. Founded in 1989 and headquartered in Cleveland, Ohio, BGL operates with a clear philosophy: clients receive hands-on guidance from partners and Managing Directors who have spent decades in their respective sectors, not junior bankers reading from playbooks. The firm's core principles—integrity, accountability, commitment, and relationship focus—define how they approach every engagement. BGL believes that exceptional outcomes in M&A stem from combining institutional process rigor with genuine sector expertise and exhaustive buyer outreach. The firm's sweet spot is global middle-market companies ($25M-$500M+ enterprise value) seeking strategic guidance on M&A, capital markets, restructuring, and valuations.
Sector Specialization
BGL maintains deep sector coverage across eight primary verticals, each led by experienced Managing Directors:
Consumer & Food/Beverage: BGL's Consumer and Food & Beverage teams have closed hundreds of transactions in branded consumer products, food processing, vitamins/supplements, and food service. Recent notable transactions include the sale of Western Botanicals (a VMS CDMO) to Riverside Company in February 2026, demonstrating expertise in contract manufacturing and private equity take-private scenarios. The team advises on category economics, consolidation dynamics, and buyer appetite across food distribution, specialty foods, nutraceuticals, and consumer staples.
Healthcare & Life Sciences: With five dedicated Managing Directors, this practice covers medical devices, diagnostics, specialty pharmaceuticals, biotech services, and healthcare IT. The team has closed deals ranging from early-stage biotech acquisitions to nine-figure roll-ups of physician practices and behavioral health platforms. They understand FDA pathways, reimbursement dynamics, and the strategic landscape of larger healthcare players consolidating middle-market assets.
Industrials: BGL's largest practice by transaction volume. The Industrials team covers manufacturing (discrete and process), building products, industrial distribution, logistics, and specialized services. A signature transaction was the sale of Boston Valley Terra Cotta to RAF Equity in February 2026, a $1B+ category company in specialized architectural manufacturing. The team has particular depth in precision machining, engineered products, equipment manufacturing, and contract services.
Infrastructure & Environmental Services: Led by Co-CEOs and specialized Managing Directors, this team focuses on environmental services, waste management, field services, and critical infrastructure maintenance. The merger of Vecta Environmental Services with EnviroVac in February 2026 illustrates their playbook: identifying complementary regional players and executing platform combinations with geographic expansion potential.
Business Services & Staffing: Deep relationships with PE sponsors seeking platform acquisitions in business services, staffing, facilities management, and outsourced operations. The team understands the economics of recurring revenue, margin expansion opportunities, and add-on acquisition targets.
Technology: While not a mega-tech specialist, BGL covers industrial software, IT services/MSPs, business software, and technology-enabled services. Expertise includes understanding how tech impacts traditional industries—IoT in manufacturing, SaaS in industrial, digital services in field operations.
Real Estate: A dedicated real estate advisory team covering development financing, commercial real estate transactions, asset sales, and restructuring for real estate companies and developers.
Buyer Network & Deal Execution
BGL maintains deep relationships with 2,000+ institutional capital providers, including:
- Private Equity Firms: Riverside Company, RAF Equity, Genstar Capital, Audax, NewSpring Capital, Oaktree Capital, and dozens of lower-middle-market sponsors
- Strategic Acquirers: Larger industrials, healthcare conglomerates, and roll-up platforms in niche sectors
- Family Offices & Wealth Managers: Direct buyers and co-investors
- International Buyers: Cross-border deals through REACH Cross-Border M&A partnership (operations in 30 countries)
Recent transaction flow demonstrates active buyer appetite: Western Botanicals to Riverside (Q1 2026), Boston Valley Terra Cotta to RAF Equity (Q1 2026), Vecta to EnviroVac (Q1 2026), GENDA's acquisition of Indigo NewCo (Q4 2025), ERG sale to Arcwood Environmental (Q4 2025), and others. This suggests BGL is generating 50-100+ transactions annually across its eight sectors.
Process & Engagement Model
BGL's process is institutional yet personalized. On sell-side mandates:
- Comprehensive business assessment and market scoping
- Targeted buyer outreach (100-300+ buyers depending on business size/sector)
- Robust Q&A management and data room organization
- Buyer negotiations with seller counsel support
- Deal closing support and integration advisory (optional)
Engagement timelines typically run 6-12 months for complex businesses. The firm is willing to run full processes for mid-market owners who value exhaustive outreach, or lighter-touch engagements for sellers with existing buyer relationships.
Fee structure is negotiable but typically follows modified Lehman on transaction value, with retainers credited against success fees. BGL will take on recaps, buy-side advisory, capital raises, and restructuring cases—not pure M&A shops.
Competitive Positioning
BGL differentiates through:
- Sector Depth: 50+ Managing Directors focused on specific industries vs. generalists
- Operational Understanding: Many bankers have operational backgrounds (former plant managers, COOs, healthcare operators)
- Independence: Partnership-owned means aligned incentives and long-term client focus, not quarterly revenue targets
- Global Reach + Local Execution: REACH partnership provides international deal access without losing local relationship management
- Process Rigor: 35+ years of middle-market deals means proven playbooks for everything from buyer identification to closing mechanics
- Honesty: Partnership culture means relationship-first advisory, not deal-at-any-cost mentality
Not a Fit If
BGL typically declines:
- Businesses below $5M EBITDA (under-resourced)
- Situations requiring rushed 60-90 day sales (need time for comprehensive outreach)
- Asset sales without operational substance
- Sellers expecting exclusive agreements (BGL runs open processes)
- Clients unable to tolerate full market testing
Geographic Coverage & Offices
Headquartered in Cleveland, Ohio with primary offices in Boston, Chicago, Los Angeles, and New York. Through REACH, serves clients globally in 30+ countries with a focus on US lower-middle and core middle market.
Team Leadership
BGL is led by two Co-CEOs: Andrew K. Petryk (Industrials) and Effram E. Kaplan (Infrastructure/Services), both Managing Directors with 25+ years of transaction experience. Leadership across sectors includes Daniel J. Gomez (Consumer/Food & Beverage), John C. Riddle (Healthcare), and specialized teams in every major sector. The firm employs 300+ professionals including 50+ Managing Directors.
Track Record & Scale
BGL has executed 300+ transactions over 35 years, with deal values ranging from $10M to $1B+. The firm is a FINRA-registered broker-dealer (CRD# 29540), enabling equity capital markets advisory alongside M&A. This regulatory standing gives clients confidence in deal execution and positions BGL to handle complex transactions requiring securities expertise.